INE203A01020
INE203A01020
ASTRAZENECA PHARMA INDIA LTD.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 145.8B EUR | 205.43B EUR | 193.99B EUR | 225.18B EUR |
Enterprise Value | 142.43B EUR | 205.43B EUR | 190.62B EUR | 225.18B EUR |
Valuation Multiples | ||||
Trailing P/E | 85.95x | 121.11x | 103.45x | 157.87x |
Forward P/E | -- | -- | -- | -- |
Price to Sales | 5.99x | 8.45x | 8.52x | 13.27x |
Price to Book | 16.7x | -- | 22.23x | -- |
EV/Revenue | 5.86x | 8.45x | 8.38x | 13.27x |
EV/EBITDA | 63.12x | 80.14x | 65.61x | 100.68x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -- | -- | -- | -- |